Gullberg Maria, Lohse Louise, Bøtner Anette, McInerney Gerald M, Burman Alison, Jackson Terry, Polacek Charlotta, Belsham Graham J
DTU National Veterinary Institute, Technical University of Denmark, Lindholm, Kalvehave, Denmark.
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
PLoS One. 2016 Jun 13;11(6):e0157435. doi: 10.1371/journal.pone.0157435. eCollection 2016.
Foot-and-mouth disease (FMD) remains one of the most economically important infectious diseases of production animals globally. Vaccination can successfully control this disease, however, current vaccines are imperfect. They are made using chemically inactivated FMD virus (FMDV) that is produced in large-scale mammalian cell culture under high containment conditions. Here, we have expressed the FMDV capsid protein precursor (P1-2A) of strain O1 Manisa alone or with the FMDV 3C protease (3Cpro) using a "single cycle" packaged alphavirus self-replicating RNA based on Semliki Forest virus (SFV). When the FMDV P1-2A was expressed with 3Cpro then processing of the FMDV capsid precursor protein is observed within cells and the proteins assemble into empty capsid particles. The products interact with anti-FMDV antibodies in an ELISA and bind to the integrin αvβ6 (a cellular receptor for FMDV). In cattle vaccinated with these rSFV-FMDV vectors alone, anti-FMDV antibodies were elicited but the immune response was insufficient to give protection against FMDV challenge. However, the prior vaccination with these vectors resulted in a much stronger immune response against FMDV post-challenge and the viremia observed was decreased in level and duration. In subsequent experiments, cattle were sequentially vaccinated with a rSFV-FMDV followed by recombinant FMDV empty capsid particles, or vice versa, prior to challenge. Animals given a primary vaccination with the rSFV-FMDV vector and then boosted with FMDV empty capsids showed a strong anti-FMDV antibody response prior to challenge, they were protected against disease and no FMDV RNA was detected in their sera post-challenge. Initial inoculation with empty capsids followed by the rSFV-FMDV was much less effective at combating the FMDV challenge and a large post-challenge boost to the level of anti-FMDV antibodies was observed. This prime-boost system, using reagents that can be generated outside of high-containment facilities, offers significant advantages to achieve control of FMD by vaccination.
口蹄疫(FMD)仍然是全球养殖动物中最具经济重要性的传染病之一。疫苗接种能够成功控制这种疾病,然而,目前的疫苗并不完美。它们是使用在高防护条件下大规模哺乳动物细胞培养中产生的化学灭活口蹄疫病毒(FMDV)制成的。在此,我们使用基于Semliki森林病毒(SFV)的“单循环”包装甲病毒自我复制RNA单独表达了O1 Manisa株的FMDV衣壳蛋白前体(P1-2A),或与FMDV 3C蛋白酶(3Cpro)一起表达。当FMDV P1-2A与3Cpro一起表达时,在细胞内观察到FMDV衣壳前体蛋白的加工过程,并且这些蛋白组装成空衣壳颗粒。这些产物在酶联免疫吸附测定(ELISA)中与抗FMDV抗体相互作用,并与整联蛋白αvβ6(FMDV的一种细胞受体)结合。在用这些重组SFV-FMDV载体单独接种的牛中,可诱导产生抗FMDV抗体,但免疫反应不足以提供针对FMDV攻击的保护。然而,预先用这些载体接种会导致在受到FMDV攻击后产生更强的免疫反应,并且观察到的病毒血症在水平和持续时间上均有所降低。在随后的实验中,在攻击前,牛先用重组SFV-FMDV接种,随后再接种重组FMDV空衣壳颗粒,或者反之。先用重组SFV-FMDV载体进行初次接种然后用FMDV空衣壳加强免疫的动物在攻击前显示出强烈的抗FMDV抗体反应,它们受到疾病保护,并且在攻击后其血清中未检测到FMDV RNA。先用空衣壳接种随后再接种重组SFV-FMDV在对抗FMDV攻击方面效果要差得多,并且在攻击后观察到抗FMDV抗体水平大幅提高。这种初免-加强系统使用可以在高防护设施外生产的试剂,为通过疫苗接种实现口蹄疫的控制提供了显著优势。